Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
abbv 744 | 0.44 | 0.1 | 8793 | 93 |
abbv 744 clinical trial | 1.58 | 0.4 | 7749 | 79 |
abbv 744 mechanism of action | 1.1 | 0.9 | 6124 | 44 |
abbv-cls-484 clinical trial | 1.82 | 0.1 | 9552 | 83 |
abbv-668 clinical trials | 1.01 | 0.1 | 9756 | 68 |
abbv-744 | 1.23 | 0.3 | 3566 | 69 |
abbvie phase 1 clinical trials | 0.57 | 0.1 | 6929 | 3 |
avb 001 clinical trial | 0.33 | 0.8 | 5258 | 24 |
10.1126/sciadv.abb4429 | 1.52 | 0.2 | 5743 | 82 |
10.1126/sciadv.abb7788 | 0.46 | 0.2 | 2403 | 68 |
10.1126/sciadv.abb1724 | 0.99 | 0.7 | 6825 | 99 |
is abbv an oncology | 0.44 | 0.6 | 4569 | 55 |
10.1126/sciadv.abb6772 | 1.18 | 0.9 | 5793 | 96 |
10.1126/sciadv.abb1342 | 1.99 | 0.5 | 5270 | 61 |
10.1126/sciadv.abb3188 | 1.81 | 0.4 | 627 | 9 |
10.1126/sciadv.abb4696 | 1.58 | 0.9 | 2036 | 84 |
10.1126/sciadv.abb1952 | 1.14 | 0.4 | 3258 | 8 |
10.1126/sciadv.abb2695 | 0.77 | 0.8 | 2389 | 26 |
abbvie clinical trials grayslake | 0.66 | 0.6 | 4111 | 86 |
10.1126/sciadv.abb3108 | 1.62 | 0.1 | 1164 | 50 |
10.1126/sciadv.abb2412 | 0.02 | 0.1 | 8628 | 24 |
10.1126/sciadv.abb6003 | 0.72 | 0.9 | 843 | 45 |
abbv-cls-484 cas | 1.49 | 0.9 | 6820 | 44 |
abbv-cls-484 ac484 | 1.15 | 0.3 | 6144 | 62 |
abbv-514 | 0.14 | 1 | 177 | 48 |
abbv-637 | 1.99 | 0.2 | 9069 | 28 |
rituximab-abbs | 0.91 | 0.8 | 6122 | 51 |